Blood tests for brain injury and neurodegeneration promise faster triage in emergency departments and earlier Alzheimer's diagnosis in memory clinics, but the science moves faster than regulatory clearance and reimbursement policy. This report maps the biomarkers, platforms and patent positions across traumatic brain injury and neurodegenerative disease testing.
Three pages from this report, open in full. The rest opens when you own it.
Eight parts, the same tabs you get when you own the report.
7 use cases
The technology recommended for each, with the alternatives.
+ 4 more
12 classes
Every class compared, with its patent trend and leading players.
+ 9 more
6 sectors
Mapped against the classes, with who sits in each.
Published November 2026 · © 2026 Berkeley FIT LLC. All rights reserved.
+ 3 more
48 companies
Searchable and filterable by sector, class and relevance.
+ 45 more
875 products
The products behind the companies, grouped by class.
+ 872 more
2,300 patents
Dominant and emerging holders for each mechanism of action.
+ 7 more
4 pathways
What each means for timelines and cost.
2 catalogs
Take the data with you.